Lipoprotein(a): A New Risk Factor for Vascular Disease

Abstract

Get full access to this article

View all access options for this article.

References

Gotto AM Jr , LaRosa JC , Hunninglake D. , et al. The cholesterol facts. A summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease. Circulation 81: 1721-1733, 1990 .

Grundy SM Cholesterol and coronary heart disease. A new era. JAMA 256:2849-2858, 1986.

Brown MS , Goldstein JL Teaching old dogmas new tricks. Nature 330:113-114, 1987.

Scanu AM , Lawn RM , Berg K. Lipoprotein(a) and atherosclerosis. Ann Intern Med 115: 209-218, 1991.

Dahlen G. , Ericson C. A new lipoprotein pattern in patients with angina pectoris. Scand j Clin Lab Invest Suppl 118:54, 1971.

Papadapoulos NM , Bedynek L. Serum lipoprotein patterns in patients with coronary atherosclerosis. Clin Chim Acta 44:153-157, 1973.

Insull W. , Najmi M. , Vloedman DA Plasma pre-beta lipoprotein sub-fractions in diagnosis of coronary artery disease [abstract]. Circulation 45(Suppl II): II-170, 1972.

Rhoads GG , Dahlen G. , Berg K. , et al. Lp(a) lipoprotein as a risk factor for myocardial infarction . JAMA 256:2540-2544, 1986 .

Dahlen GH , Guyton JR , Attar M. , et al. Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography . Circulation 74:758-765, 1986.

10.

Seed M. , Hoppichler F. , Reaveley D. , et al. Relation of serum lipoprotein (a) concentration and apolipoprotein (a) phenotype to coronary heart disease in patients with familial hypercholesterolemia . N Engl J Med 322:1494-1499, 1990 .

11.

Gries A. , Nimpf J. , Nimpf M. , et al. Free and apo B-associated Lp(a)-specific protein in human serum . Clin Chim Acta 164:93-100, 1987.

12.

Armstrong VW , Cremer P. , Eberle E. , et al. The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels. Atherosclerosis 62:249-257, 1986.

13.

Durrington PN , Ishola M. , Hunt L. , et al. Apolipoproteins (a), A1, and B and parental history of men with early onset ischemic heart disease. Lancet 1(8594):1070-1073, 1988 .

14.

Kostner GM , Avogaro P. , Cazzolato G. , et al. Lipoprotein Lp(a) and the risk for myocardial infarction. Atherosclerosis 38:51-61, 1981.

15.

Koltringer P. , Jurgens G. A dominant role of lipoprotein(a) in the investigation and evaluation of parameters indicating the development of cervical atherosclerosis . Atherosclerosis 58:187-198, 1985.

16.

Hoefler G. , Harnoncourt F. , Paschke E. , et al. Lipoprotein Lp(a): A risk factor for myocardial infarction. Arteriosclerosis 8:398-401, 1988.

17.

Rosengren A. , Wilhelmsen L. , Eriksson E. , et al. Lipoprotein(a) and coronary heart disease: A prospective case-control study in a general population sample of middle-aged men. Br Med J 301:1248-1251, 1990.

18.

Sandkamp M. , Funke H. , Schulte H. , et al. Lipoprotein (a) is an independent risk factor for myocardial infarction at a young age. Clin Chem 36:20-23, 1990.

19.

Hoff HF , Beck GJ , Skibinski CI , et al. Serum Lp(a) level as a predictor of vein graft stenosis after coronary artery bypass surgery in patients. Circulation 77:1238-1244, 1988.

20.

Cushing GL , Gaubatz JW , Nava ML , et al. Quantitation and localization of apolipoproteins(a) and B in coronary artery bypass vein grafts resected at re-operation. Arteriosclerosis 9:593-603, 1989.

21.

Rath M. , Niendorf A. , Reblin T. , et al. Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary artery bypass patients. Arteriosclerosis 9:579-592, 1989.

22.

Walton KW , Hitchens J. , Magnani AL , et al. A study of methods of identification and estimation of Lp(a) lipoprotein and of its significance in health, hyperlipidaemia, and atherosclerosis . Atherosclerosis 20:323-346, 1974.

23.

Pepin JM , O'Neil JA , Hoff HF Quantification of apo(a) and apoB in human atherosclerotic lesions. J Lipid Res 32:317-327, 1991.

24.

Smith EB , Cochran S. Factors influencing the accumulation in fibrous plaques of lipid derived from low density lipoprotein. II: Preferential immobilization of lipoprotein (a) . Atherosclerosis 84:173-181, 1990.

25.

Zenker G. , Koltringer P. , Bone G. , et al. Lipoprotein (a) as a strong indicator for cerebrovascular disease . Stroke 17:942-945, 1986.

26.

Jurgens G. , Koltringer P. Lipoprotein(a) in ischemic cerebrovascular disease: A new approach to the assessment of risk for stroke. Neurology 37:513-515, 1987.

27.

Murai A. , Miyahara T. , Fujimoto N. , et al. Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction. Atherosclerosis 59:199-204, 1986.

28.

Norrgard O. , Angquist KA , Dahlen G. Lp(a) lipoprotein in patients with arterial insufficiency of the lower extremities. Eur J Vasc Surg 5:277-282, 1991.

29.

Berg K. Lp(a) lipoprotein: An overview. In Scanu AM , ed. Lipoprotein(a). San Diego: Academic Press, 1990, pp 1-23.

30.

Mbewu AD , Durrington PN Lipoprotein(a): Structure, properties and possible involvement in thrombogenesis and atherogenesis. Atherosclerosis 85:1-14, 1990.

31.

Loscalzo J. Lipoprotein(a). A unique risk factor for atherothrombotic disease. Arteriosclerosis 10:672-679, 1990.

32.

McLean JW , Tomlinson JE , Kuang WJ , et al. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 330:132-137, 1987.

33.

Scanu AM Lipoprotein(a): A genetically determined pathogen in search of a function . J Lab Clin Med 116:142-146, 1990.

34.

Scanu AM Lipoprotein(a): A potential bridge between the fields of atherosclerosis and thrombosis. Arch Pathol Lab Med 112:1045-1047, 1988.

35.

Scanu AM , Fless GM Lipoprotein(a). Heterogeneity and biological relevance. J Clin Invest 85:1709-1715, 1990.

36.

Ginsberg HN Lipoprotein physiology and its relationship to atherogenesis. Endocrinol Metab Clin North Am 19:211-228, 1990.

37.

Morrisett JD , Gaubatz JW , Knapp RD , et al. Structural properties of apo(a): A major lipoprotein of human lipoprotein(a). In Scanu AM , ed. Lipoprotein(a). San Diego: Academic Press, 1990, pp 53-74.

38.

Utermann G. , Kraft HG , Menzel HJ , et al. Genetics of qualitative Lp(a) lipoprotein trait. I. Relationship of Lp(a) glycoprotein phenotypes to Lp(a) lipoprotein concentrations in plasma. Hum Genet 78:41-46, 1988.

39.

Lackner C. , Boerwinkle E. , Leffert CC , et al. Molecular basis of apolipoprotein(a) isoform size heterogeneity as revealed by pulse-field gel electrophoresis. J Clin Invest 87:2077-2086, 1991.

40.

Utermann G. , Menzel HJ , Kraft HG , et al. Lp(a) glycoprotein phenotypes: Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. J Clin Invest 80:458-465, 1987.

41.

Utermann G. Genetics of the Lp(a) lipoprotein. In Scanu AM , ed. Lipoprotein(a). San Diego: Academic Press, 1990, pp 75-85.

42.

Hegele RA , Emi M. , White RL , et al. Lipoprotein(a) and plasminogen: Linkage analysis. In Scanu AM , ed. Lipoprotein(a). San Diego: Academic Press, 1990, pp 129-139.

43.

Utermann G. The mysteries of lipoprotein(a). Science 246:904-910, 1989.

44.

Dahlen GH Incidence of Lp(a) lipoprotein among populations. In Scanu AM , ed. Lipoprotein(a). San Diego: Academic Press, 1990 , pp 151-173.

45.

Guyton JR , Dahlen GH , Patsch W. , et al. Relationship of plasma lipoprotein Lp(a) levels to race and to apolipoprotein B. Arteriosclerosis 5:265-272, 1985.

46.

Boerwinkle E. , Menzel HJ , Kraft HG , et al. Genetics of the quantitative Lp(a) lipoprotein trait. III. Contribution of Lp(a) glycoprotein phenotypes to normal lipid variation. Hum Genet 82:73-78, 1989.

47.

Kostner GM The physiological role of Lp(a). In Scanu AM , ed. Lipoprotein(a). San Diego: Academic Press, 1990, pp 183-204.

48.

Kraft HG , Menzel HJ , Hoppichler F. , et al. Changes of genetic apolipoprotein phenotypes caused by liver transplantation. Implications for apolipoprotein synthesis. J Clin Invest 83: 137-142, 1989.

49.

Tomlinson JE , McLean JW , Lawn RM Rhesus monkey apolipoprotein(a): Sequence, evolution, and site of synthesis. J Biol Chem 264:5957-5965, 1989.

50.

Utermann G. , Hoppichler F. , Dieplinger H. , et al. Defects in the low density lipoprotein receptor gene affect lipoprotein(a) levels: Multiplicative interaction of two gene loci associated with premature atherosclerosis. Proc Natl Acad Sci USA 86:4171-4174, 1989 .

51.

Hofmann SL , Eaton DL , Brown MS , et al. Overexpression of human low density lipoprotein receptors leads to accelerated catabolism of Lp(a) lipoprotein in transgenic mice. J Clin Invest 85:1542-1547, 1990 .

52.

Maartmann-Moe K. , Berg K. Lp(a) lipoprotein enters cultured fibroblasts independently of the plasma membrane low density lipoprotein receptor . Clin Genet 20:352-362, 1981.

53.

Floren CH , Albers JJ , Bierman EL Uptake of Lp(a) lipoprotein by cultured fibroblasts. Biochem Biophys Res Commun 102:636-639, 1981.

54.

Krempler F. , Kostner GM , Roscher A. , et al. Studies on the role of specific cell surface receptors in the removal of lipoprotein(a) in man. J Clin Invest 71:1431-1441, 1983 .

55.

Miles LA , Fless GM , Levin EG , et al. A potential basis for the thrombotic risks associated with lipoprotein(a) . Nature 339:301-303, 1989.

56.

Hajjar KA , Gavish D. , Breslow JL , et al. Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis. Nature 339:303-305, 1989.

57.

Parra HJ , Mezdour H. , Cachera C. , et al. Lp(a) lipoprotein in patients with chronic renal failure treated by hemodialysis [abstract]. Clin Chem 33:721, 1987.

58.

Jenkins AJ , Steele JS , Janus ED , et al. Increased plasma apolipoprotein(a) levels in IDDM patients with microalbuminuria. Diabetes 40:787-790, 1991.

59.

Meilahn EN , Kuller LH , Matthews KA , et al. Lp(a) concentrations among pre- and post-menopausal women over time: The healthy women study [abstract]. Circulation 84: 546, 1991.

60.

Kervinen K. , Savolainen JM , Kesaniemi YA A rapid increase in lipoprotein(a) levels after ethanol withdrawl in alcoholic men. Life Sci 48:2183-2188, 1991.

61.

Maeda S. , Abe A. , Seishima M. , et al. Transient changes of serum lipoprotein(a) as an acute phase protein. Atherosclerosis 78:145-150, 1989.

62.

Kawade M. , Maeda S. , Abe A. , et al. Alterations in plasma Lp(a) lipoprotein and acute phase proteins after surgical operation [abstract]. Clin Chem 30:941, 1984.

63.

Wallberg-Jonsson S. , Rantapaa-Dahlqvist M. , Stromqvist M. , et al. Lipids and apolipoproteins in rheumatoid arthritis [abstract]. Scand J Rheum 17:505, 1988.

64.

Albers JJ , Adolphson JL , Hazzard WR Radioimmunoassay of human plasma Lp(a) lipoprotein. J Lipid Res 18:331-338, 1977.

65.

Albers JJ , Marcovina SM , Lodge MS The unique lipoprotein(a): Properties and immunochemical measurement . Clin Chem 36:2019-2026, 1990 .

66.

Eaton DL , Fless GM , Kohr WJ , et al. Partial amino acid sequence of apolipoprotein(a) shows that it is homologous to plasminogen. Proc Natl Acad Sci USA 84:3224-3228, 1987.

67.

Edelberg JM , Gonzales-Gronow M. , Pizzo SV Lipoprotein(a) inhibits streptokinase mediated activation of human plasminogen . Biochemistry 28:2370-2374, 1989 .

68.

Hajjar KA , Nachman RL Endothelial cell-mediated conversion of glu-plasminogen to lys-plasminogen . J Clin Invest 82:1769-1778, 1988 .

69.

Edelberg JM , Pizzo SV Lipoprotein(a): The link between impaired fibrinolysis and atherosclerosis. Fibrinolysis 5:135-143, 1991.

70.

Etingin OR , Hajjar DP , Hajjar KA , et al. Lipoprotein(a) regulates plasminogen activator inhibitor-1 expression in endothelial cells. J Biol Chem 266:2459-2465, 1991.

71.

Ross R. The pathogenesis of atherosclerosis: An update. N Engl J Med 314:488-500, 1986.

72.

Schafer AI The hypercoagulable states. Ann Intern Med 102:814-828, 1985.

73.

Lawn RM Lipoprotein(a) in heart disease. Sci Am 266:54-60, 1992.

74.

Pepin JM , O'Neil JA , Hoff HF Quantification of apo(a) and apo B in human atherosclerotic lesions. J Lipid Res 32:317-327, 1991.

75.

Haberland ME , Fless GM , Scanu AM , et al. Malondialdehyde modification of Lp(a) produces avid uptake by human monocyte-macrophages. J Biol Chem 267:4143-4151, 1992.

76.

Naruszewicz M. , Selinger E. , Davignon J. Oxidation of Lp(a) particles increases their uptake by macrophages [abstract]. Arteriosclerosis 10:808a, 1990.

77.

Scanu AM Lipoprotein(a). A genetic risk factor for premature coronary disease . JAMA 267:3326-3329, 1992 .

78.

Mudd SH , Levy HL , Skovby F. Disorders of transsulfuration. In Scriver CR , Beaudet AL , Sly WS , et al., eds. The Metabolic Basis of Inherited Disease . New York: McGraw-Hill, 1989, pp 693-734.

79.

Matsumoto K. , Nakamura T. Hepatocyte growth factor: Molecular structure, roles in liver regeneration, and other biological functions. Crit Rev Oncogen 3:27-54, 1992.

80.

Albers JJ , Cabana VG , Warnick GR , et al. Lp(a) lipoprotein: Relationship to sinking pre-beta lipoprotein hyperlipoproteinemia, and apolipoprotein B. Metabolism 24: 1047-1054, 1975.

81.

Brewer HB Effectiveness of diet and drugs in the treatment of patients with elevated Lp(a) levels. In Scanu AM , ed. Lipoprotein(a). San Diego: Academic Press, 1990, pp 211-220.

82.

Kostner GM , Gavish D. , Leopold B. , et al. HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels. Circulation 80:1313-1319, 1989.

83.

Carlson LA , Hamsten A. , Asplund A. Pronounced lowering of serum levels of lipoprotein(a) in hyperlipidaemic subjects treated with nicotinic acid. J Intern Med 226:271-276, 1989.

84.

Gurakar A. , Hoeg JM , Kostner G. , et al. Levels of lipoprotein(a) decline with neomycin and niacin treatment . Atherosclerosis 57:293-301, 1985.

85.

Armstrong VW , Schleef J. , Thiery J. , et al. Effect of HELP-LDL-apheresis on serum concentrations of human lipoprotein(a): Kinetic analysis of the post-treatment return to baseline levels. Eur J Clin Invest 19:235-240, 1989.

86.

Rader DJ , Brewer HB Lipoprotein(a): Clinical approach to a unique atherogenic lipoprotein . JAMA 267:1109-1112, 1992 .

87.

Atherosclerosis Study Group. Optimal resources for primary prevention of atherosclerotic diseases. Circulation 70:157A-205A, 1984.